chinese medicine
Trump Administration Weighs Severe Restrictions on US Pharmas Licensing Chinese Medicines
Trump administration; Chinese medicines; executive order; pharmaceutical industry; licensing restrictions; national security; lobbying; Pfizer; AstraZeneca; biotech; drug manufacturing; FDA review